Hepatitis B Virus Reactivation in Patients With HBV-Related Advanced Hepatocellular Carcinoma Undergoing Lenvatinib and Camrelizumab Treatment

Hepatitis B Virus Reactivation in Patients With HBV-Related Advanced Hepatocellular Carcinoma Undergoing Lenvatinib and Camrelizumab Treatment

Objective This study aimed to evaluate hepatitis B virus (HBV) reactivation and its effect on tumor response and survival outcomes in patients with HBV-related advanced hepatocellular carcinoma (HCC) undergoing lenvatinib plus camrelizumab treatment. Methods 216 patients with HBV-related advanced HC...

Full description

Saved in:
Bibliographic Details
Main Authors: Bi Sheng MD, Dong Wang MD, Jingjing Wang MD
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748241309046
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items